Kevin De Jonghe — Vrije Universiteit Brussel

Laarbeeklaan 101
1090 Brussels
Belgium

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Unpublished abstract
1 Article

The development of radiolabeled nanobodies against the next-generation immune checkpoint TIGIT for non-invasive immune phenotyping of tumors
Zeven, K., De Groof, T., Awad, R. M., De Mey, W., Ertveldt, T., Ceuppens, H., De Jonghe, K., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 2023.
Research output: Unpublished contribution to conference › Unpublished abstract
Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at the tumor microenvironment
Ertveldt, T., Breckpot, K., Devoogdt, N., Puttemans, J., De Veirman, K., Krasniqi, A., Ceuppens, H., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., Keyaerts, M., D'Huyvetter, M., Bruchertseifer, F. & Morgenstern, A., 6 Dec 2022, (Accepted/In press) Journal of Nuclear Medicine.
Research output: Contribution to specialist/vulgarizing publication › Article › Specialist

1 Other
1 Talk or presentation at a conference

The development of radiolabeled nanobodies against the next-generation immune checkpoint TIGIT for non-invasive immune phenotyping of tumors
Katty Zeven (Speaker), Timo De Groof (Contributor), Robin Maximilian Awad (Contributor), Wout De Mey (Contributor), Thomas Ertveldt (Contributor), Hannelore Ceuppens (Contributor), Kevin De Jonghe (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Karine Breckpot (Contributor) & Nick Devoogdt (Contributor)
16 Mar 2023
Activity: Talk or presentation › Talk or presentation at a conference
2020-69
Marleen Keyaerts (Supervisor), Ahmet Krasniqi (Contributor), Cindy Peleman (Contributor), Kevin De Jonghe (Contributor) & Yoline Lauwers (Contributor)
2020
Activity: Other